ReviewCells2022

Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?

Rita Assi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.